Investment Rating - The report assigns an "Outperform" rating to multiple companies including Nike, JD Group, and Midea Group, while some companies like Lululemon are rated as "Neutral" [1]. Core Insights - The implementation of major infrastructure projects is driving the outperformance of traditional consumption stocks with low valuations and expectations, while new consumption concepts are under pressure [20]. - The report highlights a rotation in investment focus from high-valuation, high-expectation new consumption stocks to low-valuation, low-expectation traditional consumption stocks [5][12]. Weekly Performance Review - The weekly performance of various sectors shows that daily necessities, domestic cosmetics, and domestic sportswear outperformed MSCI China, while overseas sportswear, pets, and gold jewelry sectors experienced negative growth [4][10]. - The life necessities sector saw a weekly increase of 7.6%, with Baiya shares rising by 15.5% [5][12]. - Domestic cosmetics increased by 2.8%, driven by rising cases of mosquito-borne diseases in southern China, benefiting companies like Runben and Shanghai Jahwa [5][12]. - The luxury goods sector rose by 2.2%, with LVMH showing signs of recovery in its second-quarter performance [5][12]. Valuation Analysis - Most sectors are still valued below their average over the past five years, with the overseas sportswear sector expected PE at 33.9 times, which is 55% of its historical average [15]. - The domestic sportswear sector has a projected PE of 13.3 times, representing 77% of its historical average [15]. - The luxury goods sector is projected to have a PE of 25.2 times, which is 45% of its historical average [15]. Company-Specific Insights - Companies like Anta Sports and Li Ning have shown mixed performance, with Li Ning increasing by 2.5% while Anta faced challenges due to rumors of narrowing brand acquisition [11][12]. - The report notes that several new consumption companies will face unlock events, with significant percentages of their shares becoming tradable in the coming months [13][14].

Investment Rating - The report initiates coverage with an OUTPERFORM rating, setting a target price of Rmb 419.80, indicating a potential upside of 25.5% from the current price of Rmb 338.65 [2][9]. Core Insights - Shanxi Jinbo Bio-Pharmaceutical is a leading domestic company in the industrialization of recombinant human collagen, holding three Class III medical device certificates for its products, which positions it favorably in the market [3][11]. - The company reported a revenue of Rmb 1.44 billion in 2024, reflecting a year-on-year growth of 84.92%, driven by significant increases in its medical devices, functional skincare products, and raw materials segments [3][8]. - The report anticipates revenue growth for 2025-2027 to reach Rmb 2.17 billion, Rmb 2.92 billion, and Rmb 3.72 billion, respectively, with growth rates of 55%, 37%, and 29% [9]. Summary by Sections Company Overview - Shanxi Jinbo Bio-Pharmaceutical specializes in recombinant collagen medical devices, with a focus on injectable products that are classified as Class III medical devices, which have stringent approval processes and high technical barriers [3][11]. - The company has established a significant market presence with its proprietary brand Wei Yimei and has also engaged in contract manufacturing for L'Oréal's SkinCeuticals brand [3][27]. Financial Performance - The company has shown consistent revenue and profit growth over the past five years, with a net profit of Rmb 732 million in 2024, up 144% year-on-year [8][9]. - The gross profit margin for 2024 was reported at 92.02%, with the medical device segment achieving a margin of 95.03% [8][9]. Product and Market Position - The medical device segment accounted for 87% of total revenue in 2024, with a compound annual growth rate (CAGR) of 94% from 2020 to 2024 [25][27]. - Jinbo Bio's main products include recombinant collagen injectables, which are primarily used in aesthetic medicine and surgical repair treatments [23][27]. Strategic Partnerships - The company has formed a strategic partnership with Yangshengtang, leveraging its extensive retail network of over 3 million outlets to enhance market penetration and brand visibility [4][20]. - This collaboration is expected to facilitate the application of Jinbo's collagen products across various sectors, including skincare and health products [4][20]. Research and Development - Jinbo Bio is actively investing in R&D, with a focus on its new drug EK1, which is in the pre-clinical stage and aims to address broad-spectrum antiviral needs [5][9]. - The company holds multiple patents for its core ingredients, enhancing its competitive edge in the high-end skincare market [4][20].

Investment Rating - The report initiates coverage with an "Outperform" rating, setting a target price of 34.29 CNY based on a cautious approach considering comparable company valuations [2][12]. Core Insights - The company is a specialized IT outsourcing provider, focusing on digital innovation technology services and general digital technology services, aiming to support various industries such as finance, internet, software, communication, smart manufacturing, and public services [2][15]. - The company has achieved significant breakthroughs in banking and automotive sectors, expanding its business into robotics and overseas markets, while establishing a "dual capability center + digital foundation" system to enhance core competitiveness [2][5]. Financial Summary - The company’s revenue is projected to grow from 4,321 million CNY in 2024 to 6,330 million CNY in 2027, reflecting a compound annual growth rate (CAGR) of approximately 15% [3][10]. - Net profit attributable to the parent company is expected to increase from 131 million CNY in 2024 to 203 million CNY in 2027, with a notable recovery in growth rates after a dip in 2023 [3][10]. - Earnings per share (EPS) are forecasted to rise from 0.31 CNY in 2024 to 0.47 CNY in 2027 [3][10]. Business Segmentation - The company’s revenue from digital innovation technology services is expected to grow at rates of 36%, 37%, and 38% from 2025 to 2027, while general digital technology services are projected to grow at 6%, 5.5%, and 5% during the same period [8][9]. - The overall revenue growth is anticipated to be 12.34%, 13.37%, and 15.03% from 2025 to 2027, with an upward trend in overall gross margin [8][9]. Strategic Focus - The company is focusing on enhancing its product capabilities in the banking sector through the "FADOs" product system, which integrates data and AI to drive business innovation [24][31]. - In the automotive sector, the company aims to provide comprehensive software services, leveraging domestic technology to support smart vehicle upgrades [32][35]. Technological Advancements - The company is building a digital foundation centered around cloud computing, big data, and AI, which will facilitate the commercialization of technological achievements [37][38]. - The establishment of a full-stack model capability is expected to enhance business automation and efficiency across key sectors such as finance and automotive [38][39].

Investment Rating - The report maintains an "OUTPERFORM" rating for Leapmotor [2][18]. Core Views - The report is optimistic about Leapmotor's significant revenue growth in 2Q25, expecting revenue to reach Rmb14.22 billion, a 187.1% year-on-year increase, driven by a 152% year-on-year and 53% quarter-on-quarter rise in sales volume [3][14]. - The gross margin is expected to slightly decline to around 13% due to industry price competition, while the SG&A expense ratio is projected to fall below 9% [3][14]. - Leapmotor's B01 model is positioned to lead the sub-100,000 Rmb pure electric sedan segment, featuring advanced technology and competitive pricing [4][15][16]. - The partnership with Stellantis is highlighted as a strategic advantage, enhancing Leapmotor's market presence and resource optimization [6][17]. Financial Summary - Revenue forecasts for Leapmotor are updated to Rmb64.0 billion for 2025, Rmb83.5 billion for 2026, and Rmb105.6 billion for 2027, reflecting a revision of -5% for 2025 and +3% for the following years [7][18]. - The company is expected to achieve profitability in 2Q25, with a forecasted net profit attributable to shareholders of Rmb120 million, corresponding to a net margin close to 1% [3][14]. - The B01 model is anticipated to achieve stable domestic monthly sales of 15,000 units, with potential growth in overseas markets [5][16].

Investment Rating - The report assigns an "Outperform" rating to multiple companies including Pop Mart, Anta Sports, Haidilao, and Miniso, while Budweiser APAC is rated "Neutral" [1]. Core Insights - The report highlights significant developments in the F&B, designer toys, and home appliance sectors, indicating a strong growth trajectory for companies like Pop Mart and Miniso, with Pop Mart aiming to become a world-class consumer brand [2][6]. - The report notes the performance of key companies, with Haidilao showing a weekly increase of 4.3%, while Nayuki and Green Tea Group experienced declines of 7.5% and 6.2% respectively [3][7]. Summary by Category F&B Sector - Haidilao's first premium store opened in Beijing, focusing on high-quality ingredients and a refined dining experience [2]. - The National Development and Reform Commission has allocated 69 billion yuan for consumer goods trade-in funds, boosting sales in the sector [2]. Designer Toys Sector - Pop Mart's production capacity has doubled, and the company is considering collaborations with major film studios [2]. - Miniso is launching a summer-themed flash store, showcasing limited edition products [2]. Home Appliance Sector - The report mentions the launch of JD's first self-service takeaway store, "Seven Fresh Kitchen," emphasizing fresh cooking without pre-prepared meals [2]. - DJI is entering the home appliance market with a new vacuum cleaner robot set to launch on August 26 [2].

Investment Rating - The report suggests a positive outlook for certain Japanese consumer companies, particularly Asics, Pan Pacific International Holdings, Fast Retailing, and Asahi Group, due to their optimistic profit growth prospects [5]. Core Insights - High temperatures in June boosted sales of beverages and summer clothing, while duty-free consumption saw a significant decline [2][13]. - The consumer confidence index in Japan rose to 34.5 in June, the highest in four months, indicating improved consumer sentiment [7]. - The report highlights a mixed performance across different sectors, with essential goods showing resilience while discretionary spending faced challenges [4][26]. Summary by Sections Macro Overview - The consumer confidence index increased to 34.5 in June, up from 32.8 in May, with all sub-indices showing improvement [7]. - Core CPI rose by 3.3% year-on-year in June, a decrease from 3.7% in May, indicating a slowdown in inflation [9]. - The producer price index (PPI) increased by 2.9% year-on-year in June, reflecting easing cost pressures for producers [11]. Essential Consumption - Drugstore same-store sales showed positive growth, with PPIH, 7-Eleven, and Aeon reporting increases of 4.5%, 2.0%, and 2.1% respectively [3][15]. - Beverage sales turned positive due to high temperatures, with Suntory and Asahi reporting year-on-year sales growth of 1% and 9% respectively [18]. - The overall beer industry faced challenges, with Asahi's domestic revenue declining by 1% and Kirin's by 2% [20]. Discretionary Consumption - Clothing sales remained robust, with Workman and Uniqlo reporting same-store sales growth of 15.0% and 6.4% respectively [28]. - Restaurant same-store sales growth slowed, with major brands like Food&Life and McDonald's showing increases of 14.5% and 3.6% respectively [26]. - Department store sales continued to decline, with a 7.8% year-on-year drop in June, primarily due to a 40.6% decrease in duty-free sales [34]. Stock Market Performance - In June, the retail sector index rose by 3.7%, while the food and beverage sector increased by 0.7% [42]. - The report notes significant inflows into retail and food and beverage ETFs, indicating investor interest in these sectors [5].

Report Industry Investment Rating No information provided regarding the report industry investment rating. Report's Core View - In Q1 2025, Bridgewater significantly reduced its U.S. equity exposure while increasing allocations to gold and China, following the All Weather strategy to hedge against macro uncertainties and systemic risks [1][21]. - This adjustment aligns with Dalio's long - term debt cycle framework, as the U.S. is in the late stage of high debt and fiscal deterioration, while China is in an earlier phase with stronger growth potential and debt resilience [1][4][21]. Summary by Relevant Catalog 1. Overall Position Adjustment in Q1 2025 - Bridgewater's total portfolio value edged down slightly from USD 21.8 billion in Q4 2024 to USD 21.6 billion in Q1 2025. The portfolio structure shifted significantly with a "East Rising, West Declining" trend, cutting U.S. stocks and adding gold and Chinese assets [6][22]. - It加仓 283 stocks, newly built positions in 123 stocks, while reducing positions in 252 stocks and liquidating 150 stocks. The proportion of the top ten holdings in the portfolio value dropped from 43.2% in the previous quarter to 31.8%, showing a more diversified portfolio [6]. 2. Top 10 Buys - Bridgewater made significant purchases of Alibaba, increasing its holdings by 2120% to 566 million shares, making it the largest single - stock holding and the fourth - largest holding overall. Alibaba's stock price rose 56% in Q1 [8]. - Newly built a position in SPDR Gold TR (GLD), with a purchase of over 1.1 million shares, making it the sixth - largest holding, which reflects the need to hedge against inflation and currency risks. The gold ETF rose nearly 19% in Q1 [9]. - Also significantly increased holdings in Baidu (+188 million shares), Pinduoduo (+50 million shares), and newly built a position in JD.com (about 278.7 million shares). It also slightly increased holdings in NIO and other Chinese concept stocks, and significantly increased the allocation of iShares MSCI Emerging Market ETF (IEMG) [10]. - Increased allocations to the financial and cyclical sectors, newly building positions in Goldman Sachs, Chubb, Bank of America, Citigroup, etc., making the financial sector the second - largest holding sector, with the weight increasing by 4.8% compared to the previous quarter [11]. 3. Top 10 Sells - Significantly reduced the position of SPDR S&P 500 ETF TR (SPY) by nearly 60%, with the holding value decreasing by about USD 2.85 billion, and the portfolio weight dropping from 22% in Q4 2024 to less than 9% [12]. - Reduced positions in large - cap technology stocks such as Google A, NVIDIA, Meta, etc., with reduction ranges between 15% - 30%. It also almost liquidated some small - and medium - sized growth stocks such as AppLovin and Robinhood [12]. - Reduced positions in healthcare companies such as Mckesson, Merck & CO, etc., and liquidated Eli Lilly, Modernam, etc. Also liquidated many stocks in the semiconductor and consumer discretionary sectors [13]. 4. Industry and Asset Allocation Changes - The industry allocation shifted from a highly concentrated technology sector to a more balanced allocation across multiple sectors such as finance and consumption, showing a more defensive and diversified trend [14]. - The proportion of commodity allocation increased, with the introduction of gold ETFs significantly increasing the proportion of precious metals in the portfolio [15]. - The financial sector became the third - largest weighted sector in Bridgewater's portfolio, with the allocation proportion increasing by 4.8% compared to Q4 2024 [15]. - The weight of the technology sector decreased relatively. Bridgewater reduced positions in some technology giants and growth stocks but still slightly increased positions in some companies with reasonable valuations or stable businesses [15]. - The medical sector was cut the most, with Bridgewater liquidating biotech companies such as Modernam due to high valuations and an unfavorable macro - environment [15]. - The consumer discretionary and other cyclical sectors showed differentiation. Bridgewater sold some consumer discretionary stocks but newly built positions in airline stocks [16]. 5. Principles Behind the Position Adjustment - Bridgewater's core investment framework is based on a long - term global macro perspective and diversified hedging. The All Weather strategy proposed in 1996 aims to build resilient portfolios. The significant increase in gold holdings reflects the principle of diversified hedging [3][17][23]. - Dalio's long - term debt cycle theory is an important basis for this position adjustment. The U.S. is in the "pre - civil war stage" of high debt and fiscal deterioration, while China is in a more favorable stage. Bridgewater's adjustment is a forward - looking layout for the "East Rising, West Declining" trend [4][18][24]. - Dalio warned about the high valuation of technology stocks, and Bridgewater reduced its technology stock allocation to avoid risks and shifted funds to more defensive or low - correlated assets [19].

[Table_Title] 研究报告 Research Report 27 Jul 2025 香港策略 Hong Kong Strategy 银行退位、蓝筹暖场，短期过热静待调整窗口 Banks Step Back, Blue Chips Warm Up — Awaiting a Cooling-Off Window After Short-Term Overheating 周林泓 Amber Zhou 李加惠 Jiahui Li, CFA amber.lh.zhou@htisec.com jh.li@htisec.com [Table_yemei1] 观点聚焦 Investment Focus [Table_summary] (Please see APPENDIX 1 for English summary) 上周我们指出，更佳的建仓时点仍有赖于市场回调，但目前短期市场表现持续强于预期，即便我们此前判断短期需 规避的银行板块已进入持续回调阶段，也未对指数上涨造成影响。这显示市场正逐步进入牛市氛围，支撑行情的长 期逻辑持续兑现，资金加速入场，原本可能引发调整的因素在当前阶段难以形成压制。恒生指数本周突破前期 ...

Investment Rating - The report maintains an "Outperform" rating for the company, with a target price of 18.82 RMB, representing a potential upside of 27% from the current price of 14.33 RMB [1][9]. Core Insights - The company's Q2 performance shows significant improvement, indicating a recovery in business momentum, with a notable increase in enterprise-level AI applications [1][9]. - Revenue for H1 2025 is projected to be between 3.56 billion RMB and 3.64 billion RMB, reflecting a year-over-year decline of 6.4% to 4.3%, while Q2 revenue is expected to be between 2.18 billion RMB and 2.26 billion RMB, showing a year-over-year growth of 6.1% to 10.0% [9]. - The company is transitioning to a subscription model and optimizing its organizational structure, which is expected to impact short-term operations but ultimately enhance revenue quality [9]. Financial Summary - Total revenue projections for 2025, 2026, and 2027 are 9.92 billion RMB, 10.92 billion RMB, and 12.26 billion RMB, respectively, with corresponding EPS estimates of -0.09 RMB, 0.07 RMB, and 0.18 RMB [3][9]. - The company anticipates a net loss attributable to shareholders in H1 2025 of 875 million to 975 million RMB, an improvement from a loss of 794 million RMB in the same period last year [9]. - Operating cash flow for Q2 is expected to show a net inflow, improving by approximately 320 million RMB year-over-year, contributing to a cumulative improvement of about 600 million RMB in H1 [9]. Business Development - The launch of Yonyou Zhiyou 3.0 marks a new phase in intelligent management, focusing on multi-agent collaboration to enhance AI application capabilities across various business scenarios [9]. - The platform supports the formation of specialized "digital intelligence teams" and enables seamless integration of data sources, breaking down data silos while ensuring security and compliance [9].

Investment Rating - The report rates the industry as "Outperform" [1] Core Insights - BYD has achieved a global milestone by realizing L4-level intelligent parking, allowing drivers to be hands-free under specific conditions, with liability on automobile companies [5][12] - xAI has released Grok-4, a next-generation large model that has seen a tenfold increase in reasoning capabilities compared to its predecessor, excelling in various benchmarks and outperforming human graduate-level academic abilities [5][13] - The Ministry of Industry and Information Technology has issued the 2025 Work Points for Integration of Informatization and Industrialization, emphasizing new industrialization and supporting software development, AI empowerment, and digital transformation [5][14] Summary of Related Companies - Recommended targets include: Empyrean Technology, Dameng Data, Beijing Kingsoft Office Software, Newland Digital Technology, Jiangsu Tongxingbao Intelligent Transportation Technology Co., Ltd., Kingdee International Software Group, Hehe Information; related target: Wuxi Unicomp Technology Co., Ltd. [5][11] - BYD's advantages in assisted driving and manufacturing ensure safety for users in the Chinese market, boosting trust in intelligent parking [5][12] - Grok-4 has demonstrated strong capabilities in real-world applications, including significant improvements in voice response speed and performance in complex tasks across various industries [5][13]